Alhemo
concizumab
- Strength
- 100 mg/mL
- Form
- Injection, Solution
- Class
- Tissue Factor Pathway Inhibitor Antagon…
Novo Nordisk
Not stocked by us — reference only
concizumab
Listed by Novo Nordisk
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Tissue Factor Pathway Inhibitor Antagonist |
| Approval route | BLA — biologic licence |
| NDC code | 0169-2081 |
| FDA application | BLA761315 |
| RxNorm concept | 2708346 |
| Package sizes listed | 1 |
| Marketed since | February 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
concizumab
Novo Nordisk
Not stocked by us — reference only
concizumab
Novo Nordisk
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.